D70.1

D70.1: Agranulocytosis secondary to cancer chemotherapy

Billable / specific codeICD-10-CM

D70.1 is a billable, specific ICD-10-CM code for agranulocytosis secondary to cancer chemotherapy. It is valid for submission on a claim.

Check D70.1 with the rest of the claim: free scrubber

Use additional code

Add a secondary code to capture the detail described below.

code for adverse effect, if applicable, to identify drug (T45.1X5)

Code also

Both codes may be needed to describe the encounter fully. Sequencing depends on the reason for the visit.

underlying neoplasm

Excludes1 inherited from the categories above D70.1

A category’s note binds every code beneath it.

Written on D70: Neutropenia

neutropenic splenomegaly (D73.81)
transient neonatal neutropenia (P61.5)

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

D70.1 is named in 10 Medicare coverage policies: 10 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A55717Billing and Coding: Lab: Flow Cytometry
A56464Billing and Coding: Flow Cytometry
A56748Billing and Coding: White Cell Colony Stimulating Factors
A57689Billing and Coding: Lab: Flow Cytometry

Alphabetic index entries that lead here

Agranulocytosis›cytoreductive cancer chemotherapy sequela
Leukopenia›chemotherapy induced(cancer)
Neutropenia, neutropenic›cytoreductive cancer chemotherapy sequela
Agranulocytosis›drug-induced›due to cytoreductive cancer chemotherapy
Leukopenia›drug induced NEC›due to cytoreductive cancer chemotherapy
Neutropenia, neutropenic›drug-induced›due to cytoreductive cancer chemotherapy
Agranulocytosis›secondary›drug-induced›due to cytoreductive cancer chemotherapy
Neutropenia, neutropenic›secondary›drug-induced›due to cytoreductive cancer chemotherapy

Code history

Unchanged in every release from FY2024 to FY2027.